Vanguard Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191M | Sell |
|
|||||
|
2025
Q1 | $201M | Sell |
|
|||||
|
2024
Q4 | $352M | Sell |
|
|||||
|
2024
Q3 | $185M | Buy |
|
|||||
|
2024
Q2 | $191M | Buy |
|
|||||
|
2024
Q1 | $157M | Buy |
|
|||||
|
2023
Q4 | $146M | Buy |
|
|||||
|
2023
Q3 | $156M | Sell |
|
|||||
|
2023
Q2 | $401M | Sell |
|
|||||
|
2023
Q1 | $584M | Buy |
|
|||||
|
2022
Q4 | $700M | Buy |
|
|||||
|
2022
Q3 | $626M | Buy |
|
|||||
|
2022
Q2 | $564M | Buy |
|
|||||
|
2022
Q1 | $663M | Buy |
|
|||||
|
2021
Q4 | $593M | Buy |
|
|||||
|
2021
Q3 | $913M | Buy |
|
|||||
|
2021
Q2 | $1.73B | Sell |
|
|||||
|
2021
Q1 | $1.11B | Buy |
|
|||||
|
2020
Q4 | $1.43B | Buy |
|
|||||
|
2020
Q3 | $914M | Buy |
|
|||||
|
2020
Q2 | $443M | Buy |
|
|||||
|
2020
Q1 | $500M | Buy |
|
|||||
|
2019
Q4 | $611M | Buy |
|
|||||
|
2019
Q3 | $519M | Buy |
|
|||||
|
2019
Q2 | $390M | Sell |
|
|||||
|
2019
Q1 | $304M | Sell |
|
|||||
|
2018
Q4 | $215M | Buy |
|
|||||
|
2018
Q3 | $284M | Buy |
|
|||||
|
2018
Q2 | $155M | Buy |
|
|||||
|
2018
Q1 | $105M | Buy |
|
|||||
|
2017
Q4 | $93M | Buy |
|
|||||
|
2017
Q3 | $88.9M | Buy |
|
|||||
|
2017
Q2 | $74.1M | Buy |
|
|||||
|
2017
Q1 | $24.7M | Buy |
|
|||||
|
2016
Q4 | $21.4M | Buy |
|
|||||
|
2016
Q3 | $22.3M | Buy |
|
|||||
|
2016
Q2 | $27.5M | Buy |
|
|||||
|
2016
Q1 | $311K | Sell |
|
|||||
|
2015
Q4 | $501K | Buy |
|